AbbVie to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
AbbVie (NYSE: ABBV) will present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
AbbVie (NYSE: ABBV) will present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021. The event will feature key executives including Michael Severino, Robert A. Michael, and Jeffrey R. Stewart, who will participate virtually at 8:40 a.m. Central time.
A live audio webcast will be available on AbbVie's Investor Relations website, with an archived version to follow later that day.
AbbVie aims to deliver innovative medicines across multiple therapeutic areas, enhancing lives and addressing future medical challenges.
Details
News Market Reaction – ABBV
The recorded move for ABBV in the trading session of this news was -0.72%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NORTH CHICAGO, Ill., June 2, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present virtually at 8:40 a.m. Central time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
View original content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference-301303334.html
SOURCE AbbVie
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.